scispace - formally typeset
Open AccessJournal ArticleDOI

SARS-CoV-2: a storm is raging.

Savannah F. Pedersen, +1 more
- 01 May 2020 - 
- Vol. 130, Iss: 5, pp 2202-2205
TLDR
Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design and the authors found that respiratory distress on admission is associated with unfavorable outcomes.
Abstract
The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this issue of the JCI, Chen and colleagues compared the clinical and immunological characteristics between moderate and severe COVID-19. The authors found that respiratory distress on admission is associated with unfavorable outcomes. Increased cytokine levels (IL-6, IL-10, and TNF-α), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFN-γ expression in CD4+ T cells are associated with severe COVID-19. Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design.

read more

Citations
More filters
Journal ArticleDOI

COVID-19 mortality risk factors in older people in a long-term care center

TL;DR: The independent prognostic factors identified in the present study can help to adjust the healthcare resources in this population in case of new outbreaks of the COVID-19 pandemic.
Journal ArticleDOI

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.

TL;DR: Cutaneous immune-mediated diseases, including psoriasis, atopic dermatitis, and hidradenitis suppurativa, are therapeutically managed with biologic and non-biologic immunosuppressive and immunomodulatory drugs during the COVID-19 pandemic.
Journal ArticleDOI

COVID-19, Virology and Geroscience: A Perspective.

TL;DR: This Perspective paper discusses about the possibility that the so-called “immunosenescence” and “inflammaging” processes, already present in a fraction of frail older adults, could allow the immune escape of SARS-CoV-2 leading to COVID-19 serious complications.
Journal ArticleDOI

Neurological consequences of COVID-19: what have we learned and where do we go from here?

TL;DR: The current body of literature regarding the central nervous system (CNS) effects of SARS-CoV-2 is summarized and several potential targets for therapeutic development to reduce neurological consequences in COVID-19 patients are discussed.
References
More filters
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Related Papers (5)